This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ito, H. Articles by Finkel, T. Search for Related Content PubMed PubMed Citation Articles by Ito, H. Articles by Finkel, T.

Endothelial Progenitor Cells as Putative Targets for Angiostatin

Laboratory of Molecular Biology [H. I., I. I. R., T. F.], Hematology Branch [M. L. B.], Cardiology Branch [A. A. Q.], and Pathology Section [K. T., V. J. F.], NHLBI, NIH, Bethesda, MD 20892-1650

Angiostatin, a product of the proteolytic cleavage of plasminogen, possesses potent antitumor and antiangiogenic properties in vivo. Studies with cultured endothelial cells suggest that under certain conditions, angiostatin inhibits the migration and proliferation of these cells or, alternatively, increases their rate of apoptosis. In general, the effects of angiostatin have been considerably less potent in vitro than in vivo. One potential explanation for this disparity is that the in vivo target of angiostatin is not the mature endothelial cell. Recently, evidence has accumulated to show that circulating endothelial progenitor cells (EPCs) contribute to neovascularization. In this study, we have isolated EPCs from human subjects and demonstrated that, in contrast to that of mature endothelial cells, the growth of EPCs is exquisitely sensitive to angiostatin. These results suggest that angiostatin and related compounds may exert their biological effects by inhibiting the contribution of EPCs to angiogenesis and not by altering the growth of mature endothelial cells.

This article has been cited by other articles:

				F. Mouquet, F. Cuilleret, S. Susen, K. Sautiere, P. Marboeuf, P. V. Ennezat, E. McFadden, P. Pigny, F. Richard, B. Hennache, et al. Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1 Eur. Heart J., April 1, 2009; 30(7): 840 - 849. [Abstract] [Full Text] [PDF]

				K. K. Hirschi, D. A. Ingram, and M. C. Yoder Assessing Identity, Phenotype, and Fate of Endothelial Progenitor Cells Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1584 - 1595. [Full Text] [PDF]

				J. M. Rademaker-Lakhai, L. V. Beerepoot, N. Mehra, S. A. Radema, R. van Maanen, J. S. Vermaat, E. O. Witteveen, C. M. Visseren-Grul, L. Musib, N. Enas, et al. Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C {beta}-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer Clin. Cancer Res., August 1, 2007; 13(15): 4474 - 4481. [Abstract] [Full Text] [PDF]

				H.-K. Oh, J.-M. Ha, E. O, B. H. Lee, S. K. Lee, B.-S. Shim, Y.-K. Hong, and Y. A. Joe Tumor Angiogenesis Promoted by Ex vivo Differentiated Endothelial Progenitor Cells Is Effectively Inhibited by an Angiogenesis Inhibitor, TK1-2 Cancer Res., May 15, 2007; 67(10): 4851 - 4859. [Abstract] [Full Text] [PDF]

				M. C. Yoder, L. E. Mead, D. Prater, T. R. Krier, K. N. Mroueh, F. Li, R. Krasich, C. J. Temm, J. T. Prchal, and D. A. Ingram Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals Blood, March 1, 2007; 109(5): 1801 - 1809. [Abstract] [Full Text] [PDF]

				G. C. Schatteman, M. Dunnwald, and C. Jiao Biology of bone marrow-derived endothelial cell precursors Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H1 - H18. [Abstract] [Full Text] [PDF]

				Y. Wu, J. E. Ip, J. Huang, L. Zhang, K. Matsushita, C.-C. Liew, R. E. Pratt, and V. J. Dzau Essential Role of ICAM-1/CD18 in Mediating EPC Recruitment, Angiogenesis, and Repair to the Infarcted Myocardium Circ. Res., August 4, 2006; 99(3): 315 - 322. [Abstract] [Full Text] [PDF]

				V. Marchetti, R. Menghini, S. Rizza, A. Vivanti, T. Feccia, D. Lauro, A. Fukamizu, R. Lauro, and M. Federici Benfotiamine Counteracts Glucose Toxicity Effects on Endothelial Progenitor Cell Differentiation via Akt/FoxO Signaling. Diabetes, August 1, 2006; 55(8): 2231 - 2237. [Abstract] [Full Text] [PDF]

				D. A. Ingram, N. M. Caplice, and M. C. Yoder Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells Blood, September 1, 2005; 106(5): 1525 - 1531. [Abstract] [Full Text] [PDF]

				G. P. Fadini, C. Agostini, A. Avogaro, U. Ghani, A. Shuaib, A. Salam, A. Nasir, U. Shuaib, T. Jeerakathil, F. Sher, et al. Endothelial Progenitor Cells in Cerebrovascular Disease * Response: Stroke, June 1, 2005; 36(6): 1112 - 1113. [Full Text] [PDF]

				P. Beaudry, J. Force, G. N. Naumov, A. Wang, C. H. Baker, A. Ryan, S. Soker, B. E. Johnson, J. Folkman, and J. V. Heymach Differential Effects of Vascular Endothelial Growth Factor Receptor-2 Inhibitor ZD6474 on Circulating Endothelial Progenitors and Mature Circulating Endothelial Cells: Implications for Use as a Surrogate Marker of Antiangiogenic Activity Clin. Cancer Res., May 1, 2005; 11(9): 3514 - 3522. [Abstract] [Full Text] [PDF]

				T. M. Powell, J. D. Paul, J. M. Hill, M. Thompson, M. Benjamin, M. Rodrigo, J. P. McCoy, E. J. Read, H. M. Khuu, S. F. Leitman, et al. Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 296 - 301. [Abstract] [Full Text] [PDF]

				X. Wang, J. Zhu, J. Chen, and Y. Shang Effects of Nicotine on the Number and Activity of Circulating Endothelial Progenitor Cells J. Clin. Pharmacol., August 1, 2004; 44(8): 881 - 889. [Abstract] [Full Text] [PDF]

				T Eizawa, U Ikeda, Y Murakami, K Matsui, T Yoshioka, M Takahashi, K Muroi, and K Shimada Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease Heart, June 1, 2004; 90(6): 685 - 686. [Full Text] [PDF]

				G. Bocci, G. Francia, S. Man, J. Lawler, and R. S. Kerbel Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy PNAS, October 28, 2003; 100(22): 12917 - 12922. [Abstract] [Full Text] [PDF]

				N. Wajih and D. C. Sane Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells Blood, March 1, 2003; 101(5): 1857 - 1863. [Abstract] [Full Text] [PDF]

				J. M. Hill, G. Zalos, J. P.J. Halcox, W. H. Schenke, M. A. Waclawiw, A. A. Quyyumi, and T. Finkel Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk N. Engl. J. Med., February 13, 2003; 348(7): 593 - 600. [Abstract] [Full Text] [PDF]

				E. Chavakis and S. Dimmeler Regulation of Endothelial Cell Survival and Apoptosis During Angiogenesis Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 887 - 893. [Abstract] [Full Text] [PDF]

				J. Folkman Can mosaic tumor vessels facilitate molecular diagnosis of cancer? PNAS, January 16, 2001; 98(2): 398 - 400. [Full Text] [PDF]

				S. Dimmeler and A. M. Zeiher Endothelial Cell Apoptosis in Angiogenesis and Vessel Regression Circ. Res., September 15, 2000; 87(6): 434 - 439. [Abstract] [Full Text] [PDF]